Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
Year: 1995
Type: article
Source: PubMed
Authors: P Dobrzanski, R P Ryseck, R Bravo
Institution: Bristol-Myers Squibb (United States)
Language: English
Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2411211523
